Muscle Relaxant Drugs Market Size

  • Report ID: 486
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Muscle Relaxant Drugs Market Size

Muscle Relaxant Drugs Market size was valued at USD 3.43 million in 2024 and is poised to cross USD 8.06 million by the end of 2037, registering more than 6.9% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of muscle relaxant drugs is estimated at USD 3.62 million.. The growth of the market can primarily be attributed to the rising number of populations suffering from musculoskeletal conditions worldwide, along with patients with lower back pain. As per recent statistics provided by the Global Burden of Disease (GBD) in the year 2019, more than 1.71 billion people live with musculoskeletal conditions around the globe.

A common problem noticed worldwide is deteriorating muscle health and an increase in muscle spasms. An upsurge in problems such as muscle cramps, sprains and strains, fibromyalgia, tendinitis, neuromuscular disorders, and many more diseases has been observed worldwide.


Muscle Relaxant Drugs Market
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 486
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of muscle relaxant drugs is estimated at USD 3.62 million.

The muscle relaxant drugs market size was valued at USD 3.43 million in 2024 and is poised to cross USD 8.06 million by the end of 2037, registering more than 6.9% CAGR during the forecast period i.e., between 2025-2037. Upsurge in the use of muscle relaxants with other anaesthetics during surgical procedures, increasing sedentary lifestyle and decreasing levels of activity will boost the market growth.

North America is likely to dominate majority industry share by 2037, driven by upsurge in healthcare expenditure, low physical activity along with the high prevalence of musculoskeletal conditions affecting people of all ages in the region.

The major players in the market include AbbVie Inc., Antisense Therapeutics Limited, Sandoz International GmbH, Abbott Laboratories, Pfizer, Inc., Merck & Co., Inc., SteriMax Inc., Vertical Pharmaceuticals, LLC, Instas Pharmaceuticals Ltd., F. Hoffmann-La Roche Ltd.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample